RANDOMIZED STUDY ASSESSING THE EFFECT OF DIGOXIN WITHDRAWAL IN PATIENTS WITH MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE - RESULTS OF THE PROVED TRIAL

被引:425
|
作者
URETSKY, BF [1 ]
YOUNG, JB [1 ]
SHAHIDI, FE [1 ]
YELLEN, LG [1 ]
HARRISON, MC [1 ]
JOLLY, MK [1 ]
AWAN, N [1 ]
SEARS, C [1 ]
SEARS, L [1 ]
BAJWA, T [1 ]
MAGLIO, C [1 ]
CARLSON, C [1 ]
CARLSON, C [1 ]
COLFER, HT [1 ]
GRAHAM, K [1 ]
SHAW, C [1 ]
COSTANTINI, PJ [1 ]
STANLEY, D [1 ]
MATHESEN, R [1 ]
DAUER, A [1 ]
HOLT, V [1 ]
DETJE, R [1 ]
CHISOLM, C [1 ]
FILIP, JR [1 ]
PERRI, S [1 ]
FISHER, M [1 ]
GREENBERG, N [1 ]
KRITCHEN, C [1 ]
GALYEAN, J [1 ]
SMITH, SJ [1 ]
GOLDSCHER, D [1 ]
DEPETRIS, S [1 ]
GOODMAN, L [1 ]
LANIER, S [1 ]
HILLIARD, G [1 ]
LUCERO, M [1 ]
KARLSBERG, R [1 ]
MACCIONI, S [1 ]
PENNOCK, P [1 ]
GALE, N [1 ]
REYNOLDS, M [1 ]
SCREWS, B [1 ]
KING, K [1 ]
RHODES, A [1 ]
VANSELOW, B [1 ]
SANDBERG, J [1 ]
YURICK, C [1 ]
SHAHIDI, FE [1 ]
SHAHIDI, J [1 ]
SOMBERG, J [1 ]
机构
[1] BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1016/0735-1097(93)90403-N
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The purpose of this study was to determine whether digoxin is effective in patients with chronic, stable mild to moderate heart failure. Background. Digoxin has been a traditional therapy in heart failure, but methodologic limitations in earlier studies have prevented definitive conclusions regarding its efficacy. Methods. Withdrawal of digoxin (placebo group, n = 46) or its continuation (digoxin group, n = 42) was performed in a prospective, randomized, double-blind, placebo-controlled multicenter trial of patients with chronic, stable mild to moderate heart failure secondary to left ventricular systolic dysfunction who had normal sinus rhythm and were receiving long-term treatment with diuretic drugs and digoxin. Results. Patients withdrawn from digoxin therapy showed worsened maximal exercise capacity (median change in exercise time -96 s) compared with that of patients who continued to receive digoxin (change in exercise time +4.5 s) (p = 0.003). Patients withdrawn from digoxin therapy showed an increased incidence of treatment failures (p = 0.039) (39%, digoxin withdrawal group vs. 19%, digoxin maintenance group) and a decreased time to treatment failure (p = 0.037). In addition, patients who continued to receive digoxin had a lower body weight (p = 0.044) and heart rate (p = 0.003) and a higher left ventricular ejection fraction (p = 0.016). Conclusions. These data provide strong evidence of the clinical efficacy of digoxin in patients with normal sinus rhythm and mild to moderate chronic heart failure secondary to systolic dysfunction who are treated with diuretics.
引用
收藏
页码:955 / 962
页数:8
相关论文
共 50 条
  • [41] The effect of concomitant use of monopril and spironolactone in patients with mild to moderate congestive heart failure
    Krstic, N.
    Pavlovic, M.
    Perisic, Z.
    Radevic, L. J.
    Lazovic, M.
    Salinger, S.
    Stojkovic, A.
    Milic, D.
    CIRCULATION, 2008, 118 (12) : E177 - E177
  • [42] The effect of the concomitant use of carvedilol and spironolactone in patients with mild to moderate congestive heart failure
    Yamada, T
    Shimonagata, T
    Kumagai, K
    Hirata, A
    Makino, N
    Kioka, H
    Fukunami, M
    CIRCULATION, 2002, 106 (19) : 353 - 353
  • [43] Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study). Part 2
    Skvortsov, A. A.
    Mareev, V. Yu.
    Nasonova, S. N.
    Sychov, A. V.
    Arbolishvili, G. N.
    Baklanova, N. A.
    Masenko, V. P.
    Belenkov, Yu. N.
    TERAPEVTICHESKII ARKHIV, 2006, 78 (09): : 61 - +
  • [44] What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial
    Eisenstein, EL
    Yusuf, S
    Bourassa, MG
    Egan, DA
    Williford, WO
    Horney, A
    Mark, D
    CIRCULATION, 2001, 104 (17) : 798 - 798
  • [45] What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial
    Eisenstein, Eric L.
    Yusuf, Salim
    Bindal, Vishal
    Bourassa, Martial G.
    Horney, Anne
    Collins, Joseph F.
    Mark, Daniel B.
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (05) : 336 - 342
  • [46] ALLOPURINOL AND FEBUXOSTAT EFFECT ON TOTAL MORTALITY IN HYPERURICEMIC PATIENTS AFFECTED BY MILD-TO-MODERATE HEART FAILURE
    Cosentino, E. R.
    Cicero, A. F. G.
    Degli Esposti, D.
    Bentivenga, C.
    Magri, G.
    Veronesi, M.
    Borghi, C.
    JOURNAL OF HYPERTENSION, 2018, 36 : E239 - E239
  • [47] EFFECTS OF 12 WEEKS OF RAMIPRIL TREATMENT ON THE QUALITY-OF-LIFE IN PATIENTS WITH MODERATE CONGESTIVE-HEART-FAILURE - RESULTS OF A PLACEBO-CONTROLLED TRIAL
    GUNDERSEN, T
    WIKLUND, I
    SWEDBERG, K
    AMTORP, O
    REMES, J
    NILSSON, B
    CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (04) : 589 - 594
  • [48] DIGOXIN AND XAMOTEROL IN PATIENTS WITH MODERATE CHRONIC HEART-FAILURE - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED-STUDY
    SORENSEN, EV
    STERNDORFF, B
    ANDERSEN, MF
    FAERGEMAN, O
    CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 (02) : 203 - 209
  • [49] DETERMINANTS OF THE INITIAL EFFECTS OF CAPTOPRIL ON BLOOD-PRESSURE, GLOMERULAR-FILTRATION RATE, AND NATRIURESIS IN MILD-TO-MODERATE CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE
    MOTWANI, JG
    FENWICK, MK
    MORTON, JJ
    STRUTHERS, AD
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (16): : 1191 - 1196
  • [50] ABSENCE OF EFFECT ON EXERCISE CAPACITY OF 12-WEEKS TREATMENT WITH RAMIPRIL IN PATIENTS WITH MODERATE CONGESTIVE-HEART-FAILURE
    GUNDERSEN, T
    SWEDBERG, K
    AMTORP, O
    REMES, J
    NILSSON, B
    EUROPEAN HEART JOURNAL, 1994, 15 (12) : 1659 - 1665